The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review

Yenny ARROYO-ROJAS; Lara RODRIGUEZ-SANCHEZ; Gianmarco COLANDREA; Hugo OTAOLA ARCA; Camille LANZ; Eric BARRET; Rafael SANCHEZ-SALAS; Petr MACEK; Xavier CATHELINEAU

doi:10.23736/S2724-6051.24.05630-1

The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review

Journal

Minerva Urology and Nephrology

ISSN

2724-6051

2724-6442

Date Issued

2024

Author(s)

Yenny ARROYO-ROJAS

Lara RODRIGUEZ-SANCHEZ

Gianmarco COLANDREA

Hugo OTAOLA ARCA

Facultad de Medicina Clínica Alemana Universidad del Desarrollo

Camille LANZ

Eric BARRET

Rafael SANCHEZ-SALAS

Petr MACEK

Xavier CATHELINEAU

Type

journal-article

Scopus ID

2-s2.0-85193205194

DOI

10.23736/S2724-6051.24.05630-1

URL

https://investigadores.udd.cl/handle/123456789/10149

Cite this document

Arroyo-Rojas, Y., Rodriguez-Sanchez, L., Colandrea, G., Otaola Arca, H., Lanz, C., Barret, E., Sanchez-Salas, R., Macek, P., & Cathelineau, X. (2024). The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: A systematic review. Minerva Urology and Nephrology, 76(2). https://doi.org/10.23736/S2724-6051.24.05630-1